Abbvie Corporation v. Samsung Bioepis Co., Ltd., 2017 FC 675

JurisdictionFederal Jurisdiction (Canada)
Subject MatterCONTRACTS,INJUNCTIONS,PRACTICE
Citation2017 FC 675
CourtFederal Court (Canada)
Date12 July 2017
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
4 practice notes
2 cases
  • Angelcare Development Inc. v. Munchkin, Inc., 2018 FC 447
    • Canada
    • Federal Court (Canada)
    • 24 Abril 2018
    ...Peripheral Vascular Inc v WL Gore & Associates, Inc, 2017 FC 585 [Bard Peripheral] and Abbvie Corporation v Samsung Bioepis Co, Ltd, 2017 FC 675 [Abbvie Corp]. He found that in order to prevent disclosure to an in-house counsel, the Court must be presented with concrete evidence that es......
  • Paid Search Engine Tools, LLC v. Google Canada Corporation, 2019 FC 559
    • Canada
    • Federal Court (Canada)
    • 1 Mayo 2019
    ...affecting even outside counsel. [74] In this regard, I adopt Justice Manson’s reasoning in Abbvie Corporation v Samsung Bioepis Co Ltd, 2017 FC 675 at para 15, 282 ACWS (3d) 43: [15] Although Bioepis also argues that their commercial business or scientific interests may be seriously harmed ......
2 firm's commentaries

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT